BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 29893224)

  • 21. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2018 Nov; 392(10159):1789-1858. PubMed ID: 30496104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2017 Sep; 390(10100):1211-1259. PubMed ID: 28919117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Gómez-Dantés H; Fullman N; Lamadrid-Figueroa H; Cahuana-Hurtado L; Darney B; Avila-Burgos L; Correa-Rotter R; Rivera JA; Barquera S; González-Pier E; Aburto-Soto T; de Castro EF; Barrientos-Gutiérrez T; Basto-Abreu AC; Batis C; Borges G; Campos-Nonato I; Campuzano-Rincón JC; de Jesús Cantoral-Preciado A; Contreras-Manzano AG; Cuevas-Nasu L; de la Cruz-Gongora VV; Diaz-Ortega JL; de Lourdes García-García M; Garcia-Guerra A; de Cossío TG; González-Castell LD; Heredia-Pi I; Hijar-Medina MC; Jauregui A; Jimenez-Corona A; Lopez-Olmedo N; Magis-Rodríguez C; Medina-Garcia C; Medina-Mora ME; Mejia-Rodriguez F; Montañez JC; Montero P; Montoya A; Moreno-Banda GL; Pedroza-Tobías A; Pérez-Padilla R; Quezada AD; Richardson-López-Collada VL; Riojas-Rodríguez H; Ríos Blancas MJ; Razo-Garcia C; Mendoza MP; Sánchez-Pimienta TG; Sánchez-Romero LM; Schilmann A; Servan-Mori E; Shamah-Levy T; Téllez-Rojo MM; Texcalac-Sangrador JL; Wang H; Vos T; Forouzanfar MH; Naghavi M; Lopez AD; Murray CJ; Lozano R
    Lancet; 2016 Nov; 388(10058):2386-2402. PubMed ID: 27720260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2016 Oct; 388(10053):1545-1602. PubMed ID: 27733282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Demographics Collaborators
    Lancet; 2024 May; 403(10440):1989-2056. PubMed ID: 38484753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 DALYs and HALE Collaborators
    Lancet; 2016 Oct; 388(10053):1603-1658. PubMed ID: 27733283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Diseases and Injuries Collaborators
    Lancet; 2020 Oct; 396(10258):1204-1222. PubMed ID: 33069326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in health among regions of Ethiopia, 1990-2019: a subnational country analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Ethiopia Subnational-Level Disease Burden Initiative Collaborators
    Lancet; 2022 Apr; 399(10332):1322-1335. PubMed ID: 35294898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Mortality Collaborators
    Lancet; 2018 Nov; 392(10159):1684-1735. PubMed ID: 30496102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subnational mapping of under-5 and neonatal mortality trends in India: the Global Burden of Disease Study 2000-17.
    India State-Level Disease Burden Initiative Child Mortality Collaborators
    Lancet; 2020 May; 395(10237):1640-1658. PubMed ID: 32413293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Maternal Mortality Collaborators
    Lancet; 2016 Oct; 388(10053):1775-1812. PubMed ID: 27733286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The state of health in Indonesia's provinces, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Indonesia Subnational Collaborators
    Lancet Glob Health; 2022 Nov; 10(11):e1632-e1645. PubMed ID: 36240829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Demographics Collaborators
    Lancet; 2020 Oct; 396(10258):1160-1203. PubMed ID: 33069325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Respiratory Tract Cancers Collaborators
    Lancet Respir Med; 2021 Sep; 9(9):1030-1049. PubMed ID: 34411511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Benign Prostatic Hyperplasia Collaborators
    Lancet Healthy Longev; 2022 Nov; 3(11):e754-e776. PubMed ID: 36273485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Fertility and Forecasting Collaborators
    Lancet; 2024 May; 403(10440):2057-2099. PubMed ID: 38521087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.